InvestorsHub Logo
icon url

criticalnugz

10/20/16 8:25 AM

#45508 RE: El_Jefe42 #45506

Hmmm, not seeing the filing.
icon url

DriftinWayOfLife

10/20/16 9:01 AM

#45517 RE: El_Jefe42 #45506

I realize that the details are quite sparse and that the devil is, as always, in the details. In a couple of weeks we will have the opportunity to ask Mark for more details regarding these notes and warrants. For now, it will be speculation.

That said....my impression is that this structure will allow SGLB to continue to keep the doors open. This structure appears to minimize the dilution effects that would have occurred had there been a private placement of shares rather than a loan. I would certainly like to know which "assets" were used to secure the loan .... The printer? A patent? All patents? What are the terms of the note? Time period? Details of the "convertible" aspect of the note... Etc etc. will the infusion of $900k be sufficient along with revenues in the near future to allow for enough time to achieve the transition and uplisting?

My initial reaction is that this is a good route - reserving the right to alter my opinion depending on the details. I am curious as to the impressions of some of the posters who have been more skeptical and negative about management.


patience and GLTA
icon url

El_Jefe42

10/20/16 3:16 PM

#45528 RE: El_Jefe42 #45506

8-K Released https://www.sec.gov/Archives/edgar/data/788611/000107878216003666/f8k102016_8k.htm

Sigma Labs Secures Loan Financing
Provides Capital for Company Growth

SANTA FE, N.M. – October 20, 2016 – Sigma Labs, Inc. (OTCQB: SGLB) (“Sigma Labs” or the “Company”), a provider of quality assurance software under the Company's PrintRite3D® brand, today announced that it has closed a private placement by the Company of Secured Convertible Notes in the aggregate principal amount of $1,000,000 (the "Notes") and three-year warrants to purchase up to 160,000 shares of the Company's common stock, under a Securities Purchase Agreement with certain accredited investors (the “Investors”). Aggregate gross proceeds, before expenses, to the Company were $900,000. The Notes are secured by the assets of the Company pursuant to a Security Agreement. Additional information regarding the financing is included in the Company's Form 8-K filed on October 20, 2016 with the Securities and Exchange Commission.

“I am very pleased to announce the closing of this financing transaction,” said Mark Cola, President and CEO of Sigma Labs. “As the Company continues to aggressively pursue new contracts and licenses of our PrintRite3D® software, this capital will help strengthen our R&D efforts as well as support new business development initiatives. We appreciate the confidence that investors have shown in Sigma Labs’ future and the increasing role we will play in the additive manufacturing applications of tomorrow.”

About Sigma Labs, Inc.
Sigma Labs, Inc. is a provider of quality assurance software under the PrintRite3D® brand and a developer of advanced, in-process, non-destructive quality assurance software for commercial firms worldwide seeking productive solutions for advanced manufacturing. For more information please visit us at www.sigmalabsinc.com.